Valeo Financial Advisors, LLC Chembio Diagnostics, Inc. Transaction History

Valeo Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 13, 2020	SELL	$2.36 - $5.6 $533 - $1,265	-226 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$4.95 - $10.5 $232 - $493	47 Added 26.26%	226 $1,000
Q2 2018 Aug 14, 2018	BUY	$7.8 - $11.1 $429 - $610	55 Added 44.35%	179 $2,000
Q1 2018 Apr 12, 2018	BUY	$7.05 - $9.0 $874 - $1,116	124 New	124 $1,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.